A Phase1/phase2，Single-arm, Open-label Study of RD14-01 in Patients With Advanced Solid Tumors

Study Summary

This study will evaluate the safety and tolerability of RD14-01, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ advanced solid tumors.

Interventions

Study Locations

Facility	City	State	Country
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	Kunming	Yunnan	China

Official Trial Information

View on ClinicalTrials.gov